Specificity
Reacts with Coxsackie virus B1. Neutralizes Coxsackie virus B1 Conn 5 strain at a titer of less than 1:16.
Application
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Suggested starting dilution for IFA is 1:1000.
Dilute with buffer pH 7.5 -8.0 containing protein or other stabilizing medium. Final working dilutions must be determined by end user.
This Anti-Coxsackievirus B1 Antibody, clone 334-4A-8F-3F is validated for use in IF for the detection of Coxsackievirus B1.
Physical form
Format: Purified
Purified immunoglobulin. Liquid in 0.02M PBS, 0.25M NaCl, pH 7.6 with 0.1% sodium azide.
Storage and Stability
Maintain at 2-8°C.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Shipping Information:
Dry Ice Surcharge & Ice Pack Shipments: $40
More Information: https://cenmed.com/shipping-returns
- UPC:
- 41202014
- Condition:
- New
- Availability:
- 3-5 Days
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- MPN:
- MAB944
- Temperature Control Device:
- Yes
